By: Kavita Bajeli-Datt
NEW DELHI: Pregabalin, which is prescribed for the treatment of chronic pain, neuropathies and certain neurological conditions, has been brought under Schedule H1 of the Drugs Rules to strengthen regulation and prevent its widespread misuse, especially among the youth.












